Method of producing disease-specific antigens
OwnerSzu-Yi Chouinventor
Life of this patent
Estimating the term…
Abstract
Embodiments of the invention generally provide methods and compositions for producing disease-specific antigens. In one aspect, the invention provides a method of producing an antigen specific for Alzheimer's disease. In another aspect, the invention provides a method of producing a polyvalent antigen for two or more diseases. In yet another aspect, compositions of antigens are prepared and provided to immunize animals and induce strong immune responses.
Claims64
A method for producing an antigen specific for one or more diseases, comprising:
- obtaining one or more disease-specific compounds for each of the one or more diseases;
- preparing the obtained one or more disease-specific compounds relating to the one or more diseases in a cross-linking solution;
- combining the prepared disease-specific compounds with a biological agent into a mixture;
- incubating the mixture at a temperature for a period of time sufficient to effect cross-linking of the disease-specific compounds into a plurality of cross-linked products;
- and
- providing the plurality of the cross-linked products as the antigen.
The method of claim 43, wherein the one or more amino acid residues are attached by synthesizing the disease-specific compounds with additional one or more amino acid residues.
A method for producing an antigen relating to Alzheimer's disease, comprising:
- obtaining at least one Alzheimer's related peptide;
- preparing the at least one Alzheimer's related peptide in a cross-linking solution;
- combining the at least one Alzheimer's related peptide with a biological agent into a mixture;
- incubating the mixture at a temperature for a period of time sufficient to effect cross-linking of the at least one Alzheimer's related peptide into a plurality of cross-linked products;
- and
- providing the cross-linked products to be used as the antigen.
A method for producing an antigen relating to at least one tumor-associated disease, comprising:
- obtaining at least one tumor-specific compound relating to the at least one tumor-associated disease;
- preparing the at least one tumor-specific compound in a cross-linking solution;
- incubating the at least one tumor-specific compound with a biological agent into a mixture;
- incubating the mixture at a temperature for a period of time sufficient to effect cross-linking of the at least one tumor-specific compound into a plurality of cross-linked products;
- and
- providing the cross-linked products to be used as the antigen.
A method for producing a polyvalent antigen for two or more tumor-associated diseases using immunotherapy, comprising:
- obtaining at least one tumor-specific compound for each of the two or more tumor-associated diseases;
- preparing the obtained two or more tumor-specific compounds relating to the two or more tumor-associated diseases in a cross-linking solution;
- combining the prepared two or more tumor-specific compounds with a biological agent into a mixture;
- incubating the mixture at a temperature for a period of time sufficient to effect cross-linking of the two or more tumor-specific compounds into a plurality of cross-linked products;
- and
- providing the plurality of the cross-linked products as the polyvalent antigen.
An antigen composition, comprising:
- a plurality of cross-linked products prepared by attaching one or more amino acid residues to a compound and combining the compound with a solution of a biological agent, having a biological activity for the one or more amino acid residues, in a cross-linking solution into a mixture at a temperature for a period of a sufficient time.
Dependencies are inferred from the claim text.